Pyxis Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Pyxis Oncology
PYXS Stock  USD 1.35  0.04  2.88%   
Pyxis Oncology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pyxis Oncology's valuation are provided below:
Gross Profit
2.8 M
Market Capitalization
86.5 M
Enterprise Value Revenue
10.3466
Revenue
2.8 M
Earnings Share
(1.58)
There are over one hundred nineteen available trending fundamental ratios for Pyxis Oncology, which can be analyzed over time and compared to other ratios. All traders should check out Pyxis Oncology's recent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 186.4 M in 2026, whereas Market Cap is likely to drop slightly above 99.6 M in 2026.

Pyxis Oncology Total Revenue

19.5 Million

Check Pyxis Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pyxis Oncology's main balance sheet or income statement drivers, such as Net Interest Income of 8.5 M, Interest Income of 8.5 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 4.52, Dividend Yield of 0.0 or PTB Ratio of 0.71. Pyxis financial statements analysis is a perfect complement when working with Pyxis Oncology Valuation or Volatility modules.
  
Build AI portfolio with Pyxis Stock
Check out the analysis of Pyxis Oncology Correlation against competitors.
For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.

Pyxis Oncology Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets156.2 M180.8 M80.4 M
Slightly volatile
Short and Long Term Debt Total24.4 M23.2 M6.4 M
Slightly volatile
Other Current Liabilities10.5 M13.1 M4.8 M
Slightly volatile
Total Current Liabilities18 M20.3 M8.4 M
Slightly volatile
Property Plant And Equipment Net13.7 M25.5 M6.8 M
Slightly volatile
Current Deferred Revenue4.4 M8.8 M2.7 M
Slightly volatile
Accounts Payable5.4 M5.6 M2.6 M
Slightly volatile
Cash16.6 M17.5 M42.5 M
Pretty Stable
Non Current Assets Total18.7 M28.5 M8.8 M
Slightly volatile
Non Currrent Assets Other16.4 M15.6 M4.3 M
Slightly volatile
Cash And Short Term Investments133.5 M146 M69.7 M
Slightly volatile
Common Stock Shares Outstanding42.6 M67.2 M38.3 M
Slightly volatile
Liabilities And Stockholders Equity156.2 M180.8 M80.4 M
Slightly volatile
Non Current Liabilities Total15.5 M16.9 M20.4 M
Slightly volatile
Capital Lease Obligations24.4 M23.2 M6.4 M
Slightly volatile
Other Current Assets3.9 M6.3 M1.9 M
Slightly volatile
Other Stockholder Equity297.4 M556.7 M145.7 M
Slightly volatile
Total Liabilities37.1 M41.9 M28.5 M
Slightly volatile
Property Plant And Equipment Gross33.1 M31.5 M8.8 M
Slightly volatile
Total Current Assets137.5 M152.3 M71.6 M
Slightly volatile
Capital Stock72.5 K69 K19 K
Slightly volatile
Net Working Capital119.5 M132 M63.2 M
Slightly volatile
Short Term Debt1.8 M1.7 M482.5 K
Slightly volatile
Common Stock72.5 K69 K19 K
Slightly volatile
Property Plant Equipment13.5 M12.8 M3.7 M
Slightly volatile
Common Stock Total Equity36.3 K39.1 K33 K
Slightly volatile
Capital Surpluse399.4 M429.2 M363.8 M
Slightly volatile
Net Receivables18 K18.9 K461.9 K
Slightly volatile
Inventory699.2 K786.6 K858.6 K
Slightly volatile
Non Current Liabilities Other15.1 M17 M18.6 M
Slightly volatile
Intangible Assets2.2 M2.3 M20.4 M
Slightly volatile

Pyxis Oncology Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income8.5 M8.1 M2 M
Slightly volatile
Interest Income8.5 M8.1 M2 M
Slightly volatile
Depreciation And Amortization3.6 M3.4 M871.1 K
Slightly volatile
Selling General Administrative21.9 M29.2 M10.9 M
Slightly volatile
Other Operating Expenses72.7 M121.4 M36.3 M
Slightly volatile
Research Development46.8 M67.6 M22.4 M
Slightly volatile
Total Operating Expenses72.6 M120.9 M36.2 M
Slightly volatile
Cost Of Revenue518.9 K546.2 K677.1 K
Slightly volatile
Selling And Marketing Expenses1.4 M1.6 M1.7 M
Slightly volatile

Pyxis Oncology Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation9.6 M14.9 M4.5 M
Slightly volatile
Begin Period Cash Flow12.2 M12.8 M30.7 M
Slightly volatile
Depreciation3.6 M3.4 M1.1 M
Slightly volatile
Capital Expenditures258.9 K272.6 K1.8 M
Pretty Stable
Change To Operating Activities1.5 M2.3 M928.6 K
Slightly volatile
Issuance Of Capital Stock99.6 M67.9 M53.4 M
Slightly volatile
Total Cash From Financing Activities52.2 M53.4 M40.9 M
Pretty Stable
End Period Cash Flow17.9 M18.9 M43 M
Pretty Stable
Change To Liabilities3.9 M4.2 M1.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.525.085.5473
Slightly volatile
Stock Based Compensation To Revenue0.640.720.7874
Slightly volatile
Capex To Depreciation0.08680.09142.8465
Slightly volatile
EV To Sales4.555.125.5911
Slightly volatile
Payables Turnover0.110.09780.3027
Slightly volatile
Sales General And Administrative To Revenue1.261.421.5468
Slightly volatile
Research And Ddevelopement To Revenue2.913.273.574
Slightly volatile
Capex To Revenue0.01180.01320.0144
Slightly volatile
Cash Per Share2.661.951.747
Slightly volatile
Days Payables Outstanding1.8 K3.4 K1.8 K
Slightly volatile
Income Quality0.60.670.7672
Slightly volatile
Intangibles To Total Assets0.01810.0190.1184
Slightly volatile
Current Ratio11.418.6119.0654
Slightly volatile
Capex Per Share0.00350.00370.0509
Very volatile
Revenue Per Share0.220.250.2714
Slightly volatile
Interest Debt Per Share0.20.310.1174
Slightly volatile
Debt To Assets0.120.12850.0392
Slightly volatile
Days Of Payables Outstanding1.8 K3.4 K1.8 K
Slightly volatile
Ebt Per Ebit1.071.020.9745
Pretty Stable
Effective Tax Rate0.02180.02450.0267
Slightly volatile
Quick Ratio11.418.6119.0654
Slightly volatile
Net Income Per E B T0.780.880.956
Slightly volatile
Cash Ratio1.21.2717.3595
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.181.151.1255
Slightly volatile
Fixed Asset Turnover0.580.660.7164
Slightly volatile
Debt Ratio0.120.12850.0392
Slightly volatile
Price Sales Ratio4.525.085.5473
Slightly volatile
Asset Turnover0.080.09250.1008
Slightly volatile
Gross Profit Margin0.780.870.9535
Slightly volatile

Pyxis Oncology Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap99.6 M104.9 M338.1 M
Slightly volatile

Pyxis Fundamental Market Drivers

Pyxis Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Pyxis Oncology Financial Statements

Pyxis Oncology shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Pyxis Oncology investors may analyze each financial statement separately, they are all interrelated. The changes in Pyxis Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pyxis Oncology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue8.8 M4.4 M
Total Revenue18.6 M19.5 M
Cost Of Revenue546.2 K518.9 K
Stock Based Compensation To Revenue 0.72  0.64 
Sales General And Administrative To Revenue 1.42  1.26 
Research And Ddevelopement To Revenue 3.27  2.91 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.25  0.22 
Ebit Per Revenue(4.99)(5.24)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pyxis Stock Analysis

When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY